Applied Genetic Technologies Corp. names ophthalmologist Dr. Matthew Feinsod interim CMO

Applied Genetic Technologies Corp. appointed opthamologist Dr. Matthew Feinsod its interim CMO.

Here's what you should know:

1. Dr. Feinsod previously served as the company's product development officer.

2. He succeeds Michael Goldstein, MD, who left the company to pursue other opportunities.

3. Dr. Feinsod holds several ophthalmology-based patents. He has also founded several companies, including Imagen Biotech, a company developing ophthalmology treatments for the unmet needs of those suffering from sight-threatening diseases.

4. Dr. Feinsod will be supported by the company's clinical team.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast